Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05852145Phase 2Recruiting
Phase 2, randomised, triple-blind trial (3 arms), sponsored by Hospital Infantil de México Federico Gómez. Primary endpoint: Mean salivary pH. Started Aug 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05852145.